Literature DB >> 32126315

Mercury-induced autoimmunity: Report of two adolescent siblings with Morvan syndrome "plus" and review of the literature.

Carlos A Pérez1, Ekta G Shah2, Ian J Butler2.   

Abstract

Heavy metal toxicity is a global health concern. Mercury intoxication has been implicated in the etiology and pathogenesis of autoimmune disease, including Morvan syndrome. We describe two siblings with overlapping features of distinct autoimmune syndromes following accidental exposure to elemental mercury. Morvan syndrome was the predominant clinical phenotype. In addition to the characteristic anti-leucine-rich glioma-inactivated protein 1 (LGI1) and anti-contactin-associated protein-like 2 (Caspr2) autoantibodies, glutamic acid decarboxylase 65-kilodalton isoform (GAD65), and N-type and P/Q-type voltage-gated calcium channel (VGCC) antibodies were detected. Treatment with chelation therapy, glucocorticoids, and intravenous immunoglobulin was unsuccessful, but complete resolution of symptoms was achieved following treatment with rituximab. Herein, we perform an extensive review of the literature with a focus on the emerging concepts of mercury-induced autoimmunity and the role of mercury in the etiopathogenesis of autoimmune diseases of the nervous system.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune; Caspr2; GAD65; LGI1; Mercury; Morvan syndrome; Rituximab; VGCC

Year:  2020        PMID: 32126315     DOI: 10.1016/j.jneuroim.2020.577197

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  2 in total

Review 1.  Mercury as a cause of membranous nephropathy and Guillain-Barre syndrome: case report and literature review.

Authors:  Chen Yawei; Sun Jing; Shi Wenju; Li Yupeng; Zhang Ping; Han Liping
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

2.  The First Case of Familiar Anti-leucine-rich Glioma-Inactivated1 Autoimmune Encephalitis: A Case Report and Literature Review.

Authors:  Chuhan Ding; Qibing Sun; Ran Li; Hanli Li; Yu Wang
Journal:  Front Neurol       Date:  2022-04-14       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.